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Objective: In this study, we tested the validity of the 2009 Chinese version of the 
King’s Health Questionnaire (KHQ) in patients with an overactive bladder (OAB).
Materials and Methods: In 2009, the Taiwan Continence Society commenced linguis-
tic validation and other elements of production required for a Chinese version of the 
KHQ. Data for the psychometric assessment came from a multicenter clinical trial. 
Patients who visited urology clinics with OAB and symptoms of urgency frequency 
with or without urge incontinence were asked to fill out the KHQ at the initial visit 
and again 1 week later. The internal consistency was measured by Cronbach’s alpha 
statistics. The test–retest method was used to compare the reliability of responses 
of the two completed questionnaires using Spearman’s rank correlation coefficient. 
An alpha value > 0.70 was considered acceptable.
Results: In total, 55 patients were enrolled, including 37 women and 18 men. Forty-
seven (85.5%) patients correctly completed both questionnaires. The alpha values 
exceeded the minimum requirement for reliability in all domains of the questionnaire, 
except for the severity measure item (0.60). The internal consistency was also con-
sistently high between tests 1 and 2 in all domains. Test–retest reliability also showed 
significant correlations between the two tests in all domains.
Conclusion: This study demonstrates that the 2009 Chinese version of the KHQ is a 
reliable instrument for assessing health-related quality of life in patients with OAB.
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1.  Introduction
An overactive bladder (OAB) is defined by the Interna-
tional Continence Society as a complex of symptoms 
characterized by urinary urgency, with or without urge 
incontinence, usually with frequency and nocturia.1 OAB 
greatly affects physical and social functioning, including 
work, sleep, and sexual and interpersonal relationships.2,3 
These symptoms can cause great discomfort, embarrass-
ment, loss of confidence, and withdrawal from social 
life.4,5 Patients often develop a variety of coping behav-
iors and strategies; for example, because of symptom 
frequency, OAB patients usually reduce water (fluid) in-
take and limit daily activities to avoid discomfort.6 To min-
imize the potential for embarrassment from incontinence 
episodes, OAB patients may wear protective garments, 
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use pads, and carry a change of clothing.4 Daily activities, 
including hobbies, household chores, and physical rec-
reation, are often scheduled around the location of toilets 
to avoid potentially embarrassing situations.7 OAB, espe-
cially in patients with urge incontinence, eventually has a 
negative impact on health-related quality of life (HRQoL).
Even though OAB is diagnosed by symptoms only, its 
assessment is very important for patients and physicians, 
especially for evaluating treatment effectiveness. Multi-
item questionnaires were introduced to evaluate the im-
pact of OAB and treatment outcomes.8–10 On the other 
hand, there is no disease-specific HRQoL instrument that 
serves as a gold standard for OAB patients.7 Kelleher et al.11 
published the King’s Health Questionnaire (KHQ), which 
covers dimensions of importance to OAB patients, partic-
ularly urgency and frequency. The KHQ was developed 
with patient input and has been validated in a large co-
hort of incontinent women.11 Reese et al.7 evaluated the 
psychometric properties of the KHQ. Their study supported 
the reliability, validity, and responsiveness to change of 
the KHQ to treatment-induced changes in HRQoL in a 
clinical trial. The authors suggested that it is reasonable 
to employ the KHQ in other studies assessing disease-
specific HRQoL in patients with OAB.7
1.1.  KHQ in traditional Chinese (2009 Chinese 
version of the KHQ, Taiwan)
The KHQ is now widely accepted as a useful instrument 
for evaluating HRQoL of OAB patients. There was a need 
to translate and validate the questionnaire in Chinese so 
that it would be available for use in Taiwanese patients. 
Linguistic validation is the first step and a very important 
part of the cultural adaptation of a questionnaire. In 2006, 
Acquadro et al.12 translated the OAB-q into 14 languages. 
The process included six steps: (1) two forward transla-
tions; (2) comparison and reconciliation of the transla-
tions; (3) back-translation; (4) comparison of the source 
and back-translation; (5) review by a urologist or gynecol-
ogist; and (6) a comprehension test, using patients.
In 2009, the Taiwan Continence Society commenced 
linguistic validation and other elements of production 
required for a Chinese version of the KHQ (Appendix).
2.  Materials and Methods
2.1.  Translations and back-translations
Two forward translations were prepared: one version was 
translated by a urologist (H.C. Kuo), and another version 
was translated by experts of a translation company. 
Comparison and reconciliation of the translations were 
performed by urologists in expert meetings via an Inter-
net Skype conference (hosted by H.C. Kuo) in Taiwan. 
The back-translated KHQ was emailed to C.J. Kelleher (the 
first author of the KHQ) for comparison of the source 
and back-translation. The final KHQ in traditional Chinese 
was reviewed by a urologist (H.C. Kuo).
2.2.  Patients
Data for the psychometric assessment came from a mul-
ticenter clinical trial. All patients visited urology clinics with 
OAB and symptoms of urgency frequency with or with-
out urge incontinence. Patients had not been treated with 
any type of antimuscarinics before the test. If they were 
taking antimuscarinics, the medicine had to be discon-
tinued for more than 2 weeks. Urinalysis was performed 
on patients, and they were proven to be free of active 
urinary tract infection. Each patient or his/her legally ac-
ceptable representative agreed to participate in the KHQ 
study. Patients with urinary retention and urodynamically-
proven detrusor underactivity, those with a postvoid re-
sidual > 150 mL, those with a neurogenic bladder that 
limited ambulation, and patients who could not record 
the KHQ were excluded.
All patients were asked to fill out the KHQ. We 
requested that patients fill out the questionnaire by 
themselves. One study nurse provided instructions to the 
patients before they began to fill out the questionnaire. 
No medication that might affect lower urinary tract func-
tion, such as antimuscarinics, alpha-blockers, tricyclic anti-
depressants, tranquilizers, sedatives, 5-alpha-reductase 
inhibitors, or baclofen was prescribed. An appointment 
was made 1 week after the initial visit, and a repeat KHQ 
was completed by all enrolled patients. Before the repeat 
questionnaire was completed, patients were questioned 
about changes in their symptoms. If there were signifi-
cant changes, they were excluded from the study.
2.3.  Validation of the Chinese version of the KHQ
The Chinese version of the KHQ includes three parts: (1) 
part 1—general health perceptions and incontinence im-
pacts; (2) part 2—impacts associated with urinary symp-
toms, including role limitations, physical limitations, social 
limitations, personal relationships, emotional problems, 
and sleep/energy disturbances; and (3) part 3—severity 
measurements. This questionnaire has been widely used 
to assess HRQoL with urinary incontinence.
Validation of the questionnaire was assessed by its 
internal consistency, and by measuring its test–retest 
reliability. The internal consistency was measured by 
Cronbach’s alpha statistics. Internal consistency refers to 
the degree of correlation among items forming a scale. 
It is expected that items forming a domain of the ques-
tionnaire should be moderately correlated with each 
other but should independently contribute to the over-
all score in that domain. It was suggested that an alpha 
value ≥ 0.7 is acceptable.13 The test–retest reliability com-
pared the responses to the two completed question-
naires using Spearman’s rank correlation coefficient. The 
interval between the two visits should not be too short 
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in case a patient remembers what he/she had answered 
in the first questionnaire. We chose 1 week as an appro-
priate interval to ensure that the urinary symptoms 
were unchanged.
3.  Results
In total, 55 patients were enrolled, including 37 women 
and 18 men. Their mean age was 56 ± 17 years (range, 
37–80 years). Forty-seven (85.5%) patients correctly 
completed both questionnaires. The other eight patients 
did not return for the repeat questionnaire. All patients 
felt that the questionnaire was easy to understand and 
complete.
3.1.  Internal consistency
Values of internal consistency using Cronbach’s alpha are 
listed in Table 1. Alpha values exceeded the minimum 
requirement for reliability in all domains of the ques-
tionnaire, except for the severity measure item (0.60). 
Good internal consistency was also shown between tests 
1 and 2 in all domains.
Table 1  Internal consistency of the Chinese version of the King’s Health Questionnaire (KHQ) for overactive bladder in 
47 patients*
KHQ domain Items (n) Test 1 Test 2 Internal consistency
General health perceptions  1 52.66 ± 18.96 48.40 ± 18.36 –
Incontinence impacts  1 68.09 ± 34.72 57.45 ± 30.06 –
Role limitations  2 28.26 ± 34.76 25.69 ± 30.06 0.92
Physical limitations  2 32.25 ± 31.51 27.31 ± 29.57 0.92
Social limitations  3 24.88 ± 31.88 22.95 ± 29.01 0.86
Personal relationships  2 20.71 ± 31.74 16.67 ± 24.27 0.92
Emotions  3 40.19 ± 32.89 35.22 ± 30.94 0.92
Sleep/energy  2 41.49 ± 29.26 32.62 ± 23.56 0.70
Severity measure  5 18.72 ± 14.35 17.59 ± 18.25 0.60
Symptom severity 11 18.47 ± 12.69 16.01 ± 13.98 0.70
*Data presented as mean ± standard deviation.
Table 2 Test–retest reliability analysis of the Chinese version of the King’s Health Questionnaire (KHQ) in 47 patients*
KHQ domain Test 1 Test 2 Rho Correlation coefficient
General health perceptions 52.66 ± 18.96 48.40 ± 18.36 0.676† 0.81
Incontinence impacts 68.09 ± 34.72 57.45 ± 30.06 0.777† 0.87
Role limitations 28.26 ± 34.76 25.69 ± 30.06 0.745† 0.85
Physical limitations 32.25 ± 31.51 27.31 ± 29.57 0.669† 0.80
Social limitations 24.88 ± 31.88 22.95 ± 29.01 0.692† 0.82
Personal relationships 20.71 ± 31.74 16.67 ± 24.27 0.641† 0.77
Emotions 40.19 ± 32.89 35.22 ± 30.94 0.715† 0.83
Sleep/energy 41.49 ± 29.26 32.62 ± 23.56 0.604† 0.74
Severity measure 18.72 ± 14.35 17.59 ± 18.25 0.755† 0.85
Symptom severity 18.47 ± 12.69 16.01 ± 13.98 0.624† 0.74
*Data presented as mean ± standard deviation; †p < 0.01.
3.2.  Test–retest reliability
Test–retest reliability also showed significant correlations 
between the two tests in all domains. The mean and stan-
dard deviation of the individual domain scores and the 
correlation of the two test results are shown in Table 2.
4.  Discussion
This study is the first multicenter validation study of a 
questionnaire concerning lower urinary tract dysfunction 
under sponsorship of the Taiwan Continence Society. 
This study demonstrated that the 2009 Chinese version of 
the KHQ is a reliable instrument for assessing the HRQoL 
of patients with OAB. The high rate of repeat question-
naire completion suggests that this questionnaire is easy 
to understand and answer.
Urinary incontinence is a complex problem resulting 
from many different causes. It is also complex because of 
the different ways and varying severities with which it 
affects the lives of sufferers. Urinary symptoms affect the 
physical, psychological, social, domestic, and interpersonal 
aspects of patients with OAB.14 Assessing the impact of 
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urinary symptoms on HRQoL should focus on different 
lifestyle aspects.
Evaluating the severity of urinary symptoms usually 
involves a record of symptom scores or a voiding diary, 
or is based on urodynamic study. Although these mea-
sures may provide valuable information regarding the 
type and severity of bladder dysfunction, they might not 
reflect the impact of urinary incontinence on patients’ 
lives. Therefore, an evaluation and assessment of the im-
pact of urinary symptoms on the QoL of different void-
ing dysfunctions should be standardized, such as in OAB 
syndrome.15
There are a number of different validated QoL ques-
tionnaires that have received widespread acceptance 
and endorsement for assessing men and women with uri-
nary incontinence, and they have been used in clinical 
trials of continence care.8–11 Among these questionnaires, 
the KHQ is considered to be good at addressing patients’ 
concepts of the disease burden and may reflect real-life 
inconvenience due to urinary symptoms.11 Therefore, 
we tried to validate this questionnaire in the Chinese 
language for future clinical studies in Taiwan.
The results of this study demonstrated that the Chinese 
version of the KHQ was excellent in terms of its internal 
consistency and test–retest reliability. Scores on the re-
peat questionnaire tended to be lower than those on the 
first one, but the difference was not statistically signifi-
cant. The cause of the lower scores on the second ques-
tionnaire might have been due to a placebo effect after 
consultation with a urologist for OAB symptoms. Never-
theless, the first and second tests both showed high in-
ternal consistency, and the correlation between the two 
tests was excellent, suggesting that the Chinese version 
of the KHQ can be accepted for assessing the impact of 
urinary symptoms on the QoL of Taiwanese patients.
The main limitation of this study was the small number 
of patients tested. However, since this study attempted 
to prove the validity of the traditional Chinese version of 
the KHQ, a small cohort such as 40 with an alpha value 
≥ 0.7 should be adequate. Furthermore, we did not per-
form a validation test because several linguistic transla-
tions of the original KHQ have been validated and adapted. 
It is thus not necessary to repeat the validation test. The 
validity of this KHQ Chinese version was proven by the 
good internal consistency and test–retest reliability in 
this study.
5.  Conclusion
This study demonstrates that the 2009 Chinese version of 
the KHQ is a reliable instrument for assessing the HRQoL 
of patients with OAB. A high internal consistency in all 
domains of the questionnaire and good test–retest reli-
ability were noted for this Chinese version of the KHQ.
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